Answers are grounded in this paper and cite their sources.
Preclinical study demonstrates extended lifespan and reduced amyloid-β toxicity in C. elegans, suggesting therapeutic potential for Alzheimer's disease.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Foster et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: